Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q3 2017 call → NOThe question asks whether management explains where the company's business is going by narrating what its counterparties are themselves doing and scaling. Let me analyze the transcript carefully. The company is MGIC Investment Corp, a private mortgage insurance company. The "counterparties" in this context would be lenders, GSEs (Fannie Mae and Freddie Mac), and possibly the FHA. Let me look at what management actually says about their forward outlook: 1. Pat Sinks discusses new business written, refinance vs purchase applications, insurance in force growth, persistency, and market share. 2. He mentions "the expanding purchase mortgage market, our company's market share of approximately 18%, the hard work and dedication of my fellow coworkers to deliver stellar customer service and the higher annual persistency resulted in a 6% increase in insurance in force." 3. On regulatory/political fronts, he discusses NAIC state capital standards, housing finance reform, FHA discussions, and PMIERs. 4. Tim Mattke discusses financial results, losses, claims, premium yields, capital, dividends, and hurricane impacts. Now, does management narrate what its counterparties (lenders, GSEs) are themselves doing and scaling? Let me look for this. The company's business is writing mortgage insurance on loans originated by lenders and sold to GSEs. The "counterparties" would be the lenders who originate loans and the GSEs who buy them. Looking at the transcript, management talks about: - New business written ($14.1 billion) - Refinance vs purchase applications - Insurance in force growth - Persistency - Market share (~18%) But do they describe what lenders or GSEs are doing in terms of their own growth, expansion, ramp, adoption, or program build-out? The discussion is mostly about: - Market conditions (refi vs purchase mix) - Their own market share - Their own persistency - Regulatory matters (FHA, GSE reform, PMIERs) There's no narration of specific lenders' or GSEs' own trajectories - no discussion of a lender's expansion plans, a GSE's new program rollout, or a counterparty's build-out that would drive MGIC's volume. The discussion of FHA is about policy and potential changes, not about FHA's own scaling that MGIC is already embedded in.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.